114 related articles for article (PubMed ID: 18925709)
1. [LRIG3 gene regulates biological activity of GL15 cell line].
Xi GF; Wu Q; Wang BF; Guo DS; Chen G; Zhang JM; Lei T
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 37(5):444-50. PubMed ID: 18925709
[TBL] [Abstract][Full Text] [Related]
2. Effect of RNAi-mediated LRIG3 gene silencing on proliferation of glioma GL15 cells and expression of PCNA and Ki-67.
Cai MJ; Xie RF; Han L; Chen RD; Wang BF; Ye F; Guo DS; Lei T
Ai Zheng; 2009 Jan; 28(1):1-4. PubMed ID: 19448407
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15).
Cai M; Han L; Chen R; Ye F; Wang B; Han F; Lei T; Guo D
Cancer Lett; 2009 Jun; 278(1):104-12. PubMed ID: 19200647
[TBL] [Abstract][Full Text] [Related]
4. Effects of RNAi-mediated gene silencing of LRIG3 expression on cell cycle and survival of glioma cells.
Cai M; Xie R; Han L; Chen R; Wang B; Ye F; Guo D; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):88-93. PubMed ID: 19224171
[TBL] [Abstract][Full Text] [Related]
5. LRIG3 modulates proliferation, apoptosis and invasion of glioblastoma cells as a potent tumor suppressor.
Guo D; Yang H; Guo Y; Xiao Q; Mao F; Tan Y; Wan X; Wang B; Lei T
J Neurol Sci; 2015 Mar; 350(1-2):61-8. PubMed ID: 25708990
[TBL] [Abstract][Full Text] [Related]
6. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).
Rafidi H; Mercado F; Astudillo M; Fry WH; Saldana M; Carraway KL; Sweeney C
J Biol Chem; 2013 Jul; 288(30):21593-605. PubMed ID: 23723069
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of LRIG3 suppresses growth and invasion of bladder cancer cells.
Qi Y; Chang L; Li H; Yu G; Xiao W; Xia D; Guan W; Yang Y; Lang B; Deng KL; Yao WM; Ye ZQ; Zhuang QY
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):111-116. PubMed ID: 23392718
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of LRIG3 in human cervical squamous cell carcinoma.
Guo L; Zhang W; Sheng Y; Chen K; Shi Q; Zhang P; Zhang R
Eur J Gynaecol Oncol; 2015; 36(4):414-9. PubMed ID: 26390694
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro.
Wang B; Han L; Chen R; Cai M; Han F; Lei T; Guo D
Cancer Biol Ther; 2009 Jun; 8(11):1018-23. PubMed ID: 19421009
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed LRIG3 gene ameliorates prostate cancer through suppression of cell invasion and migration.
Chen Y; Wang Q; Wang M; Li M
Int J Biol Macromol; 2019 Mar; 124():1-9. PubMed ID: 30412760
[TBL] [Abstract][Full Text] [Related]
11. Effect of silencing LRIG3 gene on the proliferation and apoptosis of bladder cancer T24 cells.
Yuan X; Bao S; Yang W; Ye Z
J Huazhong Univ Sci Technolog Med Sci; 2011 Apr; 31(2):220. PubMed ID: 21505989
[TBL] [Abstract][Full Text] [Related]
12. Effect of over-expressed LRIG3 on cell cycle and survival of glioma cells.
Yang H; Mao F; Zhang H; Wang B; Wan F; Guo D; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):667. PubMed ID: 22038358
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation.
Xie R; Yang H; Xiao Q; Mao F; Zhang S; Ye F; Wan F; Wang B; Lei T; Guo D
Oncol Rep; 2013 Jan; 29(1):177-84. PubMed ID: 23124613
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].
Kang CS; Pu PY; Wang GX; Li YH; Dong L; Wang H
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1503-8. PubMed ID: 15500708
[TBL] [Abstract][Full Text] [Related]
15. miR-196a targeting LRIG3 promotes the proliferation and migration of cervical cancer cells.
Qiu Y; Han Q; Lu H; Shi C
Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):180-185. PubMed ID: 33287939
[TBL] [Abstract][Full Text] [Related]
16. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract][Full Text] [Related]
17. Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis.
Abraira VE; Satoh T; Fekete DM; Goodrich LV
PLoS One; 2010 Feb; 5(2):e8981. PubMed ID: 20126551
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line.
Guo D; Han L; Shu K; Chen J; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):91-4. PubMed ID: 17393120
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.
Cheng F; Zhang P; Xiao Q; Li Y; Dong M; Wang H; Kuang D; He Y; Duan Q; Mao F; Wang B; Guo D
Front Oncol; 2019; 9():447. PubMed ID: 31245283
[TBL] [Abstract][Full Text] [Related]
20. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
